Pharmaceuticals & Biotechnology (4570)

21,127.60
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Hikma surges as investors welcome medium-term guidance

By Michele Maatouk

Date: Thursday 15 May 2025

LONDON (ShareCast) - (Sharecast News) - Shares in Hikma Pharmaceuticals surged on Thursday as investors welcomed new medium-term guidance from the company.
Alongside a sell-side analysts and investors even at its manufacturing and R&D facility in Columbus, Ohio, the pharmaceuticals group said that for group revenue, it expects a three-year compound annual growth rate of 6% to 8% between 2024 and 2027.

For operating profit, it expects a three-year compound annual growth rate of 7% to 9%.

In addition, Hikma said introduced a five-year target for group revenue to reach $5bn by 2030.

At 1235 BST, the shares were up 8.1% at 2,098p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 21,127.60
Closing Price Change 138.32
% Change 0.66 %
04-Jun-25 Close 21,127.60

Top Risers

Price Change
IXI 12.20p +8.4%
NFX 0.11p +7.3%
STX 2.58p +7.3%
INDV 1,000.00p +4.9%
HELD 0.99p +4.2%
SVNS 0.14p +3.8%
HCM 224.00p +3.2%
AVCT 36.00p +2.9%
BXP 38.50p +2.7%
OXB 334.50p +2.5%

Top Fallers

Price Change
PRM 3.19p -4.5%
POLB 3.25p -4.4%
SCLP 9.75p -2.5%
FARN 225.00p -2.2%
FUM 9.49p -2.2%
SBTX 18.63p -2.0%
ANP 437.50p -1.7%
HLN 399.00p -1.5%
AGY 6.80p -1.4%
HIK 2,100.00p -1.4%

Top of Page